In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
FILE - Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, speaks during an event about drug prices with President Donald Trump, Thursday, Nov. 6, 2025, in the Oval Office of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback